A, Characteristic increases in [Ca2+]i produced by VPAC1 agonist (100 nM) in Ca2+-free saline, in the absence and presence of lysosomal disruptor bafilomycin A1 (Baf), ryanodine receptor blocker ryanodine (Ry), IP3R inhibitors xestospongin C (XeC) and 2-aminoethoxydiphenyl borate (2-APB). B, Comparison of the effects on [Ca2+]i induced by treatments indicated in A, in cultured cardiac vagal neurons; *P < 0.05 as compared with VPAC1 agonist alone.